| aspirin versus placebo | |||
| PEP hip-fracture, 2000 | aspirin 160mg/d started preoperatively and continued for 35 days versus placebo | patients undergoing surgery for hip fracture | Double blind Follow-up duration: 35 days Australia, New Zealand, South Africa, |
| certoparine + DHE versus Unfractionated heparin | |||
| Lassen, 1989 | certoparin 3000+0.5mg DHE x1 versus placebo | Hip fracture | double blind Follow-up duration: 6 days |
| dalteparin versus placebo | |||
| Jorgensen, 1989 | dalteparin 5000 x1 versus Placebo | Hip fracture | double blind Follow-up duration: 9 days |
| extended prophylaxis versus standard prophylaxis | |||
| PENTHIFRA–PLUS (Eriksson), 2003 | 25-31 days of fondaparinux 2.5-mg once-daily versus 6-8 days of fondaparinux 2.5-mg once-daily | patients undergoing hip fracture surgery | double blind Follow-up duration: 19-23 days |
| fondaparinux versus enoxaparin | |||
| PENTHIFRA (Eriksson), 2001 | fondaparinux 2.5-mg once-daily subcutaneous, starting 6 hours after surgery versus enoxaprin 40mg once daily | hip fracture surgery | double blind Follow-up duration: 11 days 21 countries |
| nadroparin versus placebo | |||
| Sourmelis, 1995 | nadroparin 3075x1 preop, 6150x1 post op versus Placebo | Hip fracture | double blind Follow-up duration: 10-12 days |
| semuloparin versus enoxaparin | |||
| SAVE-HIP 2, 2012 NCT00721760 | Semuloparin 20 mg once-daily versus Enoxaparin 40 mg once-daily | hip fracture surgery | |
in first
in second
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
